Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Evelyn Witkin and Stephen Elledge share the 2015 Lasker Basic Medical Award
Sarah Jackson
Sarah Jackson
Published September 8, 2015
Citation Information: J Clin Invest. 2015;125(10):3727-3731. https://doi.org/10.1172/JCI84318.
View: Text | PDF
News

Evelyn Witkin and Stephen Elledge share the 2015 Lasker Basic Medical Award

  • Text
  • PDF
Abstract

Authors

Sarah Jackson

×

Figure 3

A simplified schematic of mammalian DNA damage response.

Options: View larger image (or click on image) Download as PowerPoint
A simplified schematic of mammalian DNA damage response.
In response to ...
In response to UV damage or replication fork stalling (left side), the presence of single-stranded DNA triggers binding by RPA, which independently recruits the ATR-ATRIP complex and the RAD17 complex. Subsequently, the 9-1-1 complex, composed of RAD9, RAD1, and HUS1, and TOPB1 are recruited, which in turn activates ATR. There are hundreds of downstream targets of the ATR kinase, including CHK1, BRCA1, and H2AX. This signaling cascade elicits a host of cellular responses, including DNA repair and cell cycle arrest. Improper resolution of DNA damage can trigger cell death or cellular senescence. Double-strand breaks (right side) trigger the recruitment of the MRN complex, composed of MRE11, RAD50, and NBS1, which binds and activates ATM. Similar to ATR, ATM phosphorylates a host of downstream effectors to trigger DNA damage response pathways. Studies from Stephen Elledge’s laboratory were instrumental in the understanding of how DNA damage is sensed and then leads to activation of downstream signaling cascades that trigger the DNA damage response.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts